Stallion India Fluorochemicals Ltd

The transcript does not explicitly mention details about the current or expected order book or pending orders for Stallion India Fluorochemicals Limited. However, relevant insights include: - The company is experiencing significant growth with several new plants and expansions underway (e.g., 10,000 MT R32 plant, helium plants at Khalapur and Mambattu). - Production projections indicate strong revenue growth: INR 430 crore for FY26, INR 675 crore for FY27 with the addition of new facilities, and INR 950 crore expected the subsequent year. - Management expresses confidence in sustaining a 30-35% CAGR over the next three years, supported by backward integration, higher-value products, and margin expansion. - They mention more than 200 customers across 15+ countries, indicating a robust demand pipeline. - The upcoming R32 facility aims for 50% production in the first year, with expected revenues of INR 275 crore in six months. No specific quantitative order backlog or pending orders data is disclosed.

- Stallion India Fluorochemical Limited currently is raising INR 364 crores through a rights issue for the R32 plant expansion (Page 14, 7, 15). - The management expects this to be the last equity dilution; future expansions will mainly rely on debt and warrants (debentures) rather than further equity dilution (Page 12). - The company is currently debt-free but has MOUs signed for project finance with banks and the government of Rajasthan to secure project loans quickly if needed (Page 12). - Internal accruals and the rights issue proceeds are expected to sufficiently cover upcoming CapEx and operations; no present stress on funds (Page 12). - The fund infusion from shares sold by promoters was interest-free and funneled back into the company for kickstarting projects (Page 3). In summary, the near-term fundraising is focused on an equity rights issue with ample backup plans for debt financing if required.

- Raising INR 364 crores through a rights issue for the R32 plant expansion to 10,000 metric tons capacity. - CapEx for R32 plant doubled from INR ~200 crores to INR 364 crores due to scale-up. - Helium facilities at Khalapur and Mambattu being set up with a total CapEx of INR 15-20 crores funded through internal accruals. - Plans for a new plant in Bhilwara with allotted land and associated CapEx (exact amount not specified). - Expansion involves setting up integrated chemical process plants with future phases including by-product commercialization and HFO plant. - All capital projects backed by interest-free funds or project finance; currently debt-free with no anticipated further dilution beyond current rights issue. - Target to achieve operational milestones within 6-18 months (e.g., R32 plant to start production within 6 months).

- FY26 revenue guidance is INR 430 crores, with PAT guidance of INR 40 crores. - Expect production start of R32 plant with six months production from October 2026 generating about INR 275 crores revenue and INR 66 crores PAT in first year. - FY27 revenue target is INR 550 crores and PAT INR 132 crores, combining current business and new facilities. - Next year projected turnover around INR 950 crores with full-year R32 production and growth from helium and speciality gases. - Long-term (5 years) target for helium and speciality gases revenue is INR 200 crores. - Targeting 30-35% CAGR over the next three years, with margin expansion from 10% to 24% PAT. - Growth supported by backward integration, value-added products, facility expansions (Bhilwara, Khalapur, Mambattu), and market penetration.

- Stallion India Fluorochemicals targets a 30-35% CAGR over the next three years driven by backward integration, higher value products, and margin expansion of 3-4%. - FY26 revenue guidance is INR 430 crores with PAT guidance of INR 40 crores. - For FY27, expected revenue of INR 550 crores from new facilities plus current business, with PAT between INR 180-200 crores combining all operations. - New R32 plant (10,000 MT capacity) is expected to achieve 50% production in first six months generating approx. INR 275 crores revenue and INR 66 crores PAT in FY26. - Full-year R32 production in FY27 expected to add approximately INR 550 crores revenue and INR 132 crores PAT. - Long-term target (within 5 years) for helium and specialty gases is INR 200 crores. - Current EPS for 9M FY26 stood at INR 4.15, up from INR 3.10 YoY, reflecting strong operating momentum and scalability.